• Mobile version
  • Follow us on Wechat
  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • App

Vaccine maker fined ¥9.1b over vaccine scandal

Chinese authorities yesterday handed out penalties totaling more than 9.1 billion yuan (US$1.32 billion) to a company for the illegal production of a human rabies vaccine.

The Changchun Changsheng Life Sciences Ltd. in Northeast China’s Jilin Province violated China’s laws and regulations on drug management and production supervision in producing a human rabies vaccine, according to the administrative penalty decision made by national and local drug authorities.

Violations included blending different batches of vaccine fluid, falsifying dates of production and using expired fluid to produce some of the batches, the document said.

The National Medical Products Administration annulled the rabies vaccine approval document and the certificates for related products from the company, and imposed a fine of 12.03 million yuan.

Jilin Food and Drug Administration revoked the company’s pharmaceutical production license, confiscated the illegally-produced vaccines and total income of 1.89 billion yuan from defective vaccine sales, and imposed a fine of 7.21 billion yuan.

The hefty fine of 7.21 billion yuan was three times the total value of the defective vaccines produced and sold by the company.

Individuals directly responsible for the violations in the case will be banned from carrying out drug manufacturing and operating activities, and those suspected of committing crimes will face criminal charges.

Changchun Changsheng, China’s second-largest producer of anti-rabies vaccines, was accused in July of falsifying data for a rabies vaccine and manufacturing an ineffective vaccine for babies, sparking widespread consumer anger.

Premier Li Keqiang said in July the company “violated a moral bottom line.” Li ordered a nationwide inspection of other vaccine producers.

A statement by the Shenzhen-listed company yesterday said it will compensate the family of each victim who died of its vaccines 650,000 yuan.

In China, compulsory vaccines such as DPT are given to children under a State-sponsored health program at hospitals and disease control centres. Optional vaccines such as hepatitis B, rabies and influenza are provided mainly on a commercial basis.

Related News